Selected research
Industry Research
Flowable Hemostats Industry Research Report 2026
Market perspective
The global Flowable Hemostats market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Flowable Hemostats is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Flowable Hemostats is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Flowable Hemostats is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Flowable Hemostats include Teleflex Incorporated, Baxter International and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Flowable Hemostats market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Flowable Hemostats Market by Company
Teleflex Incorporated
Baxter International
Johnson & Johnson
Flowable Hemostats Segment by Type
Porcine Gelatin
Bovine Gelatin
Flowable Hemostats Segment by Application
Orthopedic Surgery
General Surgery
Neuro and Spine Surgery
Cardiac Surgery
Vascular Surgery
Others
Flowable Hemostats Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flowable Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flowable Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flowable Hemostats.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flowable Hemostats manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flowable Hemostats by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flowable Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Porcine Gelatin
- Bovine Gelatin
Applications
- Orthopedic Surgery
- General Surgery
- Neuro and Spine Surgery
- Cardiac Surgery
- Vascular Surgery
- Others
Companies covered
- Teleflex Incorporated
- Baxter International
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Flowable Hemostats Market Size (2021-2032)
- 2.2.2 Global Flowable Hemostats Sales (2021-2032)
- 2.2.3 Global Flowable Hemostats Market Average Price (2021-2032)
- 2.3 Flowable Hemostats by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Porcine Gelatin
- 2.3.3 Bovine Gelatin
- 2.4 Flowable Hemostats by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Orthopedic Surgery
- 2.4.3 General Surgery
- 2.4.4 Neuro and Spine Surgery
- 2.4.5 Cardiac Surgery
- 2.4.6 Vascular Surgery
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Flowable Hemostats Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Flowable Hemostats Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Flowable Hemostats Revenue of Manufacturers (2021-2026)
- 3.4 Global Flowable Hemostats Average Price by Manufacturers (2021-2026)
- 3.5 Global Flowable Hemostats Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Flowable Hemostats, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Flowable Hemostats, Product Type & Application
- 3.8 Global Manufacturers of Flowable Hemostats, Established Date
- 3.9 Global Flowable Hemostats Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teleflex Incorporated
- 4.1.1 Teleflex Incorporated Company Information
- 4.1.2 Teleflex Incorporated Business Overview
- 4.1.3 Teleflex Incorporated Flowable Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teleflex Incorporated Flowable Hemostats Product Portfolio
- 4.1.5 Teleflex Incorporated Recent Developments
- 4.2 Baxter International
- 4.2.1 Baxter International Company Information
- 4.2.2 Baxter International Business Overview
- 4.2.3 Baxter International Flowable Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter International Flowable Hemostats Product Portfolio
- 4.2.5 Baxter International Recent Developments
- 4.3 Johnson & Johnson
- 4.3.1 Johnson & Johnson Company Information
- 4.3.2 Johnson & Johnson Business Overview
- 4.3.3 Johnson & Johnson Flowable Hemostats Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Johnson & Johnson Flowable Hemostats Product Portfolio
- 4.3.5 Johnson & Johnson Recent Developments
5 Global Flowable Hemostats Market Scenario by Region
- 5.1 Global Flowable Hemostats Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Flowable Hemostats Sales by Region: 2021-2032
- 5.2.1 Global Flowable Hemostats Sales by Region: 2021-2026
- 5.2.2 Global Flowable Hemostats Sales by Region: 2027-2032
- 5.3 Global Flowable Hemostats Revenue by Region: 2021-2032
- 5.3.1 Global Flowable Hemostats Revenue by Region: 2021-2026
- 5.3.2 Global Flowable Hemostats Revenue by Region: 2027-2032
- 5.4 North America Flowable Hemostats Market Facts & Figures by Country
- 5.4.1 North America Flowable Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Flowable Hemostats Sales by Country (2021-2032)
- 5.4.3 North America Flowable Hemostats Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Flowable Hemostats Market Facts & Figures by Country
- 5.5.1 Europe Flowable Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Flowable Hemostats Sales by Country (2021-2032)
- 5.5.3 Europe Flowable Hemostats Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Flowable Hemostats Market Facts & Figures by Country
- 5.6.1 Asia Pacific Flowable Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Flowable Hemostats Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Flowable Hemostats Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Flowable Hemostats Market Facts & Figures by Country
- 5.7.1 South America Flowable Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Flowable Hemostats Sales by Country (2021-2032)
- 5.7.3 South America Flowable Hemostats Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Flowable Hemostats Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Flowable Hemostats Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Flowable Hemostats Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Flowable Hemostats Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Flowable Hemostats Sales by Type (2021-2032)
- 6.1.1 Global Flowable Hemostats Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Flowable Hemostats Sales Market Share by Type (2021-2032)
- 6.2 Global Flowable Hemostats Revenue by Type (2021-2032)
- 6.2.1 Global Flowable Hemostats Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Flowable Hemostats Revenue Market Share by Type (2021-2032)
- 6.3 Global Flowable Hemostats Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Flowable Hemostats Sales by Application (2021-2032)
- 7.1.1 Global Flowable Hemostats Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Flowable Hemostats Sales Market Share by Application (2021-2032)
- 7.2 Global Flowable Hemostats Revenue by Application (2021-2032)
- 7.2.1 Global Flowable Hemostats Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Flowable Hemostats Revenue Market Share by Application (2021-2032)
- 7.3 Global Flowable Hemostats Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Flowable Hemostats Value Chain Analysis
- 8.1.1 Flowable Hemostats Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Flowable Hemostats Production Mode & Process
- 8.2 Flowable Hemostats Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Flowable Hemostats Distributors
- 8.2.3 Flowable Hemostats Customers
9 Global Flowable Hemostats Analyzing Market Dynamics
- 9.1 Flowable Hemostats Industry Trends
- 9.2 Flowable Hemostats Industry Drivers
- 9.3 Flowable Hemostats Industry Opportunities and Challenges
- 9.4 Flowable Hemostats Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst